Real-time financial, economic, and global news with market-focused context and analysis.
Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.
Flyte, a regional air mobility subsidiary of Catheter Precision, announced a strategic partnership with sports agency GSE Worldwide and PGA Tour professional Emiliano Grillo at the 2026 U.S. Open. The collaboration aims to address professional athletes' need for efficient regional travel, utilizing Flyte's fleet of Cirrus Vision Jets to offer faste…
Malcolm Mark, a director at General Dynamics Corp. (GD), executed a series of transactions on June 17, 2026, resulting in the sale of 5,480 shares of the company's common stock. The transactions were valued at approximately $2,000,200, with each share sold at a uniform price of $365.00. These sales followed the exercise of an equal number of stock …
Jaime Mateus-Tique, a director at Liquidity Services Inc., executed a significant stock sale on June 18, 2026, through an irrevocable trust. The transaction occurred amidst the company's recent strong fiscal second-quarter results, which saw earnings and revenue significantly outpace market expectations.
A federal judge in San Francisco ruled Monday that Workday Inc must face a proposed class action accusing its AI-driven human resources software of screening out applicants in ways that violate California anti-discrimination law and the federal Americans with Disabilities Act. U.S. District Judge Rita Lin denied arguments that California law cannot…
Del Taco, the second-largest Mexican quick service restaurant in the US, has reintroduced its popular slow-cooked Pork Carnitas with an expanded menu featuring five new items including breakfast options. To celebrate America's 250th birthday, Del Taco also brings back its Independence Poppers beverages and fan-favorite Funnel Cake Fries for the sum…
Dyne Therapeutics has appointed Barry Greene, an experienced biopharmaceutical industry leader, to its Board of Directors as the company approaches a transition to a commercial-stage biotech enterprise. Greene's expertise in rare diseases and successful track records in development and commercialization are expected to guide Dyne through potential …
Moody's has affirmed Shift4 Payments, Inc.'s corporate family rating at Ba3 and assigned a Ba1 rating to the company's proposed Term Loan B. Concurrently, Moody's downgraded senior unsecured notes of Shift4 Payments, LLC to B1 from Ba3, citing changes to the capital structure tied to the planned repayment of convertible notes. The ratings action an…
S&P Global Ratings upgraded Openlane Inc. (OPLN) to B+ from B after the company converted $290 million of preferred stock into common equity and reported improving credit metrics. The ratings agency also raised the issue-level rating on the term loan to B+ and kept a stable outlook, citing stronger marketplace EBITDA margins and steady finance-segm…
Laura A. Williams, Ardelyx Inc.'s Chief Patient Officer, executed a series of transactions on June 18, 2026, involving the sale of 81,898 shares and the exercise of stock options. The transactions, conducted under a pre-arranged 10b5-1 trading plan adopted in March 2026, resulted in approximately $490,487 in sales and the acquisition of 31,000 shar…
Tango Therapeutics, a clinical-stage biotechnology company specializing in precision cancer medicines, announced the appointment of Robert Azelby to its Board of Directors. Azelby's extensive experience in oncology commercialization and biopharmaceutical leadership is expected to support Tango as it advances vopimetostat, a promising PRMT5 inhibito…
National Healthcare Properties, Inc. announced the final results of its self-tender offers to repurchase up to $100 million aggregate of its Series A and Series B cumulative redeemable perpetual preferred stock. The company accepted about $25.3 million worth of shares representing approximately 14.5% and 16.6% of the outstanding Series A and B shar…
Safe Bulkers, a marine drybulk transportation service provider listed on the NYSE and Euronext Athens, announced its annual meeting of stockholders to take place on September 10, 2026, in Monaco. Stockholders of record as of July 15, 2026, are eligible to vote. Formal notice and proxy statements will be sent in due course. The company also issued f…
CervoMed Inc., a NASDAQ-listed clinical-stage biotechnology company developing treatments for age-related brain disorders, has closed a registered direct offering of 2.5 million shares at $4.00 per share, raising gross proceeds of $10 million. The company plans to use these funds for working capital and general corporate purposes as it advances its…
Centessa Pharmaceuticals plc announced that the High Court of Justice of England and Wales has approved Eli Lilly's acquisition of the company. The deal values Centessa at approximately $7.8 billion, with Lilly acquiring Centessa for $38.00 per share plus contingent value rights. The acquisition is expected to close on June 24, 2026, with Centessa'…
MoonLake Immunotherapeutics said it intends to pursue a public offering of $150 million of Class A ordinary shares, a move that coincided with a 2.8% decline in the stock in after-hours trading. The company also proposed offering pre-funded warrants and granted underwriters a 30-day option for up to $22.5 million more in shares. Proceeds are target…
Xencor Inc. (NASDAQ:XNCR) director Ellen Feigal completed a stock sale of 6,843 shares on June 18, 2026, generating $89,369 in proceeds. The transaction was facilitated through a 10b5-1 trading plan established in June 2025, leaving Feigal with a direct holding of 12,340 shares. This insider activity unfolds as the biotechnology company navigates a…
Vivani Medical, a clinical-stage biopharmaceutical company specializing in miniature, ultra long-acting drug implants, announced that CEO Adam Mendelsohn will present a company overview at the 2026 BIO International Convention. Vivani is developing NanoPortal™ implant technology targeting metabolic diseases including obesity and type 2 diabetes, ai…
uniQure N.V., a Nasdaq-listed gene therapy company, has initiated a $150 million underwritten public offering of ordinary shares and pre-funded warrants, with an option to sell an additional $22.5 million of shares. The offering is subject to market conditions and aims to support the company’s pipeline of gene therapies targeting severe diseases su…
Beyond Air, Inc., a commercial-stage medical device and biopharmaceutical company specializing in nitric oxide therapies, announced it will report its fiscal fourth quarter and full year 2026 financial results on June 26, 2026, followed by a conference call and webcast with management.
TTM Technologies (NASDAQ: TTMI) has opened a new Ultra-High-Density Interconnect (Ultra-HDI) printed circuit board manufacturing facility in Syracuse, NY. The $130 million investment, including $30 million from the U.S. Department of War, creates 400 new jobs and strengthens domestic production critical to next-generation defense systems like radar…
MoonLake Immunotherapeutics, a clinical-stage biotech company focusing on inflammatory skin and joint diseases, announced a proposed $150 million public offering of Class A ordinary shares and pre-funded warrants. The proceeds will fund research, development, and potential commercialization of their investigational therapy sonelokimab, targeting in…
Fortinet's recent rally has pushed shares near the 52-week high, but fundamentals and structural AI/security tailwinds justify further upside. With revenue acceleration, strong free cash flow and unique silicon-enabled products, Fortinet is positioned to capture outsized security spending from AI data center buildouts. This trade plan sets an entry…
MKS Inc. has officially opened its new Supercenter Factory in Penang, Malaysia, a strategic move to support the growing global demand for wafer fabrication equipment. The facility, developed in multiple phases with the first phase completed, spans 350,000 square feet and is expected to create over 1,000 jobs. This investment of more than RM400 mill…
Nvidia remains the primary beneficiary of the AI buildout. The stock trades at a premium - $208.65 today - but fundamentals (high ROE, massive free cash flow, and dominant data center positioning) support a patient long. This trade plan targets $260 with a $188 stop over a 180-trading-day horizon, balancing upside from continued data-center demand …
Options trading in Skyworks Solutions Inc. surged to 32,697 contracts at 3:40 p.m. New York time on Monday, driven almost entirely by call activity. The August 21, 2026 $95 call made up the bulk of the flow, while a smaller number of call strikes and a limited put presence accounted for the remainder.
